Abiomed Sales Boosted By Impella Reorders In Fiscal Q4
This article was originally published in The Gray Sheet
Executive SummaryAbiomed sales advanced 17% to $23 million for the most recent fiscal quarter, driven by Impella percutaneous cardiac assist system reorders, despite 68% slower growth in the customer base
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.